ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 168 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $209,784 | -7.3% | 66,178 | +45.4% | 0.00% | -20.0% |
Q2 2023 | $226,284 | +6.5% | 45,530 | +5.9% | 0.01% | 0.0% |
Q1 2023 | $212,420 | +53.5% | 43,000 | +95.5% | 0.01% | +25.0% |
Q4 2022 | $138,380 | -70.2% | 22,000 | -48.8% | 0.00% | -69.2% |
Q3 2022 | $464,000 | -5.3% | 43,000 | 0.0% | 0.01% | -13.3% |
Q2 2022 | $490,000 | +25.0% | 43,000 | 0.0% | 0.02% | +66.7% |
Q1 2022 | $392,000 | -38.9% | 43,000 | 0.0% | 0.01% | -40.0% |
Q4 2021 | $642,000 | -42.0% | 43,000 | -0.1% | 0.02% | -48.3% |
Q3 2021 | $1,106,000 | -1.3% | 43,047 | +0.1% | 0.03% | -12.1% |
Q2 2021 | $1,121,000 | -26.2% | 43,000 | 0.0% | 0.03% | -47.6% |
Q1 2021 | $1,518,000 | +39.9% | 43,000 | 0.0% | 0.06% | +31.2% |
Q4 2020 | $1,085,000 | -33.1% | 43,000 | 0.0% | 0.05% | -44.8% |
Q3 2020 | $1,622,000 | -11.9% | 43,000 | 0.0% | 0.09% | -26.9% |
Q2 2020 | $1,841,000 | +120.2% | 43,000 | 0.0% | 0.12% | +77.6% |
Q1 2020 | $836,000 | -25.2% | 43,000 | 0.0% | 0.07% | -31.6% |
Q4 2019 | $1,117,000 | – | 43,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
Navalign, LLC | 75,365 | $238,907 | 0.09% |